Usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy or rheumatoid arthritis

Joint Bone Spine

Volumn 77, Issue 2, 2010, Pages 146-150

  Goulenok, Tiphaine Miquel ^a   Meune, Christophe ^a   Gossec, Laure ^a   Dougados, Maxime ^a   Kahan, André ^a   Allanore, Yannick ^a  

^a AP HP université Paris Descartes ^*  (France)

Author keywords

Electrocardiogram; Inflammatory joint disease; Rheumatoid arthritis; Spondyloarthropathies

Indexed keywords

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ELECTROCARDIOGRAPHY; EXTRASYSTOLE; FEMALE; HEART DISEASE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SCREENING TEST; SPONDYLOARTHROPATHY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ATRIAL PREMATURE COMPLEXES; ATRIOVENTRICULAR BLOCK; BUNDLE-BRANCH BLOCK; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SPONDYLARTHROPATHIES; VENTRICULAR PREMATURE COMPLEXES;

EID: 77949773788     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.01.001     Document Type: Article

References (36)

1. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
2. Bulkley B.H., and Roberts W.C. Ankylosing spondylitis and aortic regurgitation. Circulation 48 (1973) 1014-1027
3. Nitter Hauge S., and Otterstad J.E. Characteristics of atrioventricular conduction disturbances in ankylosing spondylitis. Acta Med Scand 210 (1981) 197-200
4. Brunner F., Kunz A., Weber U., et al. Ankylosing spondylitis and heart abnormalities. Clin Rheumatol 25 (2006) 24-29
5. Yildirir A., Aksoyek S., Calguneri M., et al. QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology 39 (2000) 875-879
6. Vinsonneau U., Delluc A., Bergez C., et al. Second degree atrioventricular block in mixed connective tissue disease. Rev Med Int (2005) 656-660
7. Freeston J., Barkham N., Hensor E., et al. Ankylosing spondylitis HLA B 27 positivity and the need for biologic therapy. Joint Bone Spine 74 (2007) 140-143
8. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med 127 (1997) 621-629
9. Cathgart E.S., and Spodick D.H. Rheumatoid heart disease. N Engl J Med 266 (1962) 959-964
10. Corrao S., Sallì L., Arnone S., et al. Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease. Eur Heart J 16 (1995) 253-256
11. Wislowska M., Sypula S., and Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 18 (1999) 163-169
12. Guedes C., Bianchi-Fior P., Cormier B., et al. Cardiac manifestations of rheumatoid arthritis: case control transoesophageal echocardiography study in 30 patients. Arthritis Rheum 45 (2001) 129-135
13. Meune C., Wahbi K., Assous N., et al. Myocardial dysfunction in rheumatoid arthritis: A controlled tissue-Doppler echocardiography study. J Rheumatol 34 (2007) 2005-2009
14. Seferovic P.M., Ristié A.D., Matucci-Cerinic M., et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology 45 (2006) 39-42
15. Hardouin P., Thevenon A., Beuscart R., et al. Evaluation of cardiac involvement in advanced rheumatoid arthritis Clinical, electrocardiographic, echographic and gallium and thallium double scintigraphic study of 28 patients. Rev Rhum Mal Osteoartic 55 (1988) 683-687
16. Villeco A.S., de Liberali E., Bianchi F.B., et al. Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. Clin Exp Immunol 53 (1983) 536-540
17. Bacon P.A., and Gibson D.G. Cardiac involvement in rheumatoid arthritis. Ann Rheum Dis 33 (1974) 20-24
18. Assous N., Touzé E., Meune C., et al. Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Joint Bone Spine 74 (2007) 66-72
19. Allanore Y. Cardiovascular mortality in patients with inflammatory rheumatic disorders. Joint Bone Spine 74 (2007) 120-122
20. Watson D.J., Rhodes T., and Guess H.A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 30 (2003) 1196-1202
21. Amor B., Dougados M., and Mijivawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 57 (1990) 85-89
22. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
23. Peters M.J., Van Der Horst-Bruinsma I.E., Dijkmans B.A., et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34 (2004) 585-592
24. Sukenik S., Pras A., Buskila D., et al. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol 6 (1987) 588-592
25. Thomsen N.H., Hørslev-Petersen K., and Beyer J.M. Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankylosing spondylitis. Eur Heart J 7 (1986) 240-246
26. Droste U., and Pfluger N. ECG changes in spondylarthritis ankylopoietica in comparison with healthy control group. Z Rheumatol 35 (1976) 383-388
27. Brewerton D.A., Gibson D.G., Goddard D.H., et al. The myocardium in ankylosing spondylitis A clinical, echocardiographic, and histopathological study. Lancet 1 (1987) 995-998
28. Carter R., Riantawan P., Banham S.W., et al. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. J Respir Med 93 (1999) 700-708
29. Pham T., Gossec L., Constantin A., et al. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73 (2006) 379-387
30. Karvounaris S.A., Sidiropoulos P.I., Papadakis J.A., et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 66 (2007) 28-33
31. Chung C.P., Oeser A., Solus J.F., et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196 (2008) 756-763
32. Allanore Y., Kahan A., Sellam J., et al. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis. Clin Chim Acta 365 (2006) 143-148
33. Soubrier M., Jouanel P., Mathieu S., et al. Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis. Joint Bone Spine 75 (2008) 22-24
34. Avouac J., and Allanore Y. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opin Pharmacother 9 (2008) 1121-1128
35. Goodson N., Marks J., Lunt M., et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 64 (2005) 1595-1601
36. Weyand C.M., Gornzy J.J., Luizzo G., et al. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 76 (2001) 1011-1020